[Cutaneous side effects of targeted cancer drugs].

Below, J; Homey, B; Gerber, P A

[Cutaneous side effects of targeted cancer drugs]. / Kutane Nebenwirkungen zielgerichteter onkologischer Arzneimittel.

Below, J; Homey, B; Gerber, P A.

Affiliation

Below J; Klinik für Dermatologie, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Homey B; Klinik für Dermatologie, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Gerber PA; Klinik für Dermatologie, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland. peterarne.gerber@med.uni-duesseldorf.de.

Hautarzt ; 68(1): 12-18, 2017 Jan.

Article in De | MEDLINE | ID: mdl-27885401

Subject(s)

Antineoplastic Agents/adverse effects; Antineoplastic Agents/classification; Drug Eruptions/diagnosis; Drug Eruptions/therapy; Diagnosis, Differential; Drug Eruptions/etiology; Evidence-Based Medicine; Humans; Treatment Outcome

Key words

BRAF; Checkpoint; EGFR; MEK; PD1

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Eruptions / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Guideline Aspects: Patient_preference Limits: Humans Language: De Journal: Hautarzt Year: 2017 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google